相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recommendations for management of patients with neuroendocrine liver metastases
Andrea Frilling et al.
LANCET ONCOLOGY (2014)
A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms
M. S. Khan et al.
BRITISH JOURNAL OF CANCER (2013)
Second Primary Cancers in Subsites of Colon and Rectum in Patients With Previous Colorectal Cancer
Lifang Liu et al.
DISEASES OF THE COLON & RECTUM (2013)
Accuracy of visual assessments of proliferation indices in gastroenteropancreatic neuroendocrine tumours
Helen T. M. Young et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Dual Primary Gastric and Colorectal Cancer Is the Prognosis Better for Synchronous or Metachronous?
Megumu Watanabe et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2012)
Grading of Neuroendocrine Tumors With Ki-67 Requires High-quality Assessment Practices
Satu Maria Remes et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Objective Quantification of the Ki67 Proliferative Index in Neuroendocrine Tumors of the Gastroenteropancreatic System A Comparison of Digital Image Analysis With Manual Methods
Laura H. Tang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Malignant pancreatic neuroendocrine tumour: Lymph node ratio and Ki67 are predictors of recurrence after curative resections
Letizia Boninsegna et al.
EUROPEAN JOURNAL OF CANCER (2012)
Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors
Deepti Dhall et al.
HUMAN PATHOLOGY (2012)
The Role of 68Ga-DOTATATE PET/CT in Suspected Neuroendocrine Tumors
Alexander R. Haug et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study
G. Rindi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
Marianne Pavel et al.
NEUROENDOCRINOLOGY (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Peptides and Receptors in Image-Guided Therapy: Theranostics for Neuroendocrine Neoplasms
Richard P. Baum et al.
SEMINARS IN NUCLEAR MEDICINE (2012)
Long-Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center
Olov Norlen et al.
WORLD JOURNAL OF SURGERY (2012)
Metachronous Double Primary Cancer after Diagnosis of Gastric Cancer
Jin Young Kim et al.
CANCER RESEARCH AND TREATMENT (2012)
Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver: Implications for Prognostic Stratification
Zhaohai Yang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Survival and prognostic factors in patients with small bowel carcinoid tumour
K. Landerholm et al.
BRITISH JOURNAL OF SURGERY (2011)
Neuroendocrine Tumors of Midgut and Hindgut Origin: Tumor-Node-Metastasis Classification Determines Clinical Outcome
Henning Jann et al.
CANCER (2011)
Ki-67 index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas
O. Hentic et al.
ENDOCRINE-RELATED CANCER (2011)
The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
Ben Lawrence et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2011)
Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression
Francesco Panzuto et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors
Simon Schimmack et al.
LANGENBECKS ARCHIVES OF SURGERY (2011)
Tumour evolution inferred by single-cell sequencing
Nicholas Navin et al.
NATURE (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)
R. Garcia-Carbonero et al.
ANNALS OF ONCOLOGY (2010)
The Impact of 68Ga-DOTATOC Positron Emission Tomography/Computed Tomography on the Multimodal Management of Patients With Neuroendocrine Tumors
Andrea Frilling et al.
ANNALS OF SURGERY (2010)
Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients
Aldo Scarpa et al.
MODERN PATHOLOGY (2010)
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Peter J. Campbell et al.
NATURE (2010)
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Li Ding et al.
NATURE (2010)
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Shinichi Yachida et al.
NATURE (2010)
Impact of Multiphase Ga-68-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors
Juri Ruf et al.
NEUROENDOCRINOLOGY (2010)
Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease
A. Frilling et al.
BRITISH JOURNAL OF SURGERY (2009)
Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma
Cosimo Durante et al.
ENDOCRINE-RELATED CANCER (2009)
Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study
A. Ahmed et al.
ENDOCRINE-RELATED CANCER (2009)
Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors
Stefano La Rosa et al.
HUMAN PATHOLOGY (2009)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors
Anne Couvelard et al.
MODERN PATHOLOGY (2009)
Thirteen-Month Registration of Patients with Gastroenteropancreatic Endocrine Tumours in France
C. Lombard-Bohas et al.
NEUROENDOCRINOLOGY (2009)
Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution
Sara Ekeblad et al.
CLINICAL CANCER RESEARCH (2008)
Predicting Prognosis in Gastroentero-Pancreatic Neuroendocrine Tumors: An Overview and the Value of Ki-67 Immunostaining
Mina Jamali et al.
ENDOCRINE PATHOLOGY (2008)
Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours
Ulrich-Frank Pape et al.
ENDOCRINE-RELATED CANCER (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
TNM staging of midgut and hindgut (neuro) endocrine tumors:: a consensus proposal including a grading system
G. Rindi et al.
VIRCHOWS ARCHIV (2007)
TNM staging of foregut (neuro)endocrine tumors:: a consensus proposal including a grading system
G. Rindi et al.
VIRCHOWS ARCHIV (2006)
Usefulness of Ki-67 for predicting the metastatic potential of rectal carcinoids
Kinichi Hotta et al.
PATHOLOGY INTERNATIONAL (2006)
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization
F Panzuto et al.
ENDOCRINE-RELATED CANCER (2005)
Pulmonary atypical carcinoid: Predictors of survival in 106 cases
MB Beasley et al.
HUMAN PATHOLOGY (2000)
分享论文
